Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon alpha-2a in previously treated patients with multiple myeloma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C5F0C0DF.svg?ark=w1%2F20260515%2FC5F0C0DF)](https://nobleid.org/work/w1/20260515/C5F0C0DF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors